Drug Profile
Hydrocortisone dual release - ViroPharma Incorporated
Alternative Names: Dual-release hydrocortisone; PlenadrenLatest Information Update: 16 Jan 2022
Price :
$50
*
At a glance
- Originator DuoCort
- Class Anti-inflammatories; Antiallergics; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Adrenal insufficiency
Most Recent Events
- 11 Mar 2014 ViroPharma is now called Shire ViroPharma
- 24 Jan 2014 ViroPharma has been acquired by Shire
- 20 Sep 2012 Launched for Adrenal insufficiency in Denmark (PO) - First global launch